GC Biopharma Corp - Company Profile

All the data and insights you need on GC Biopharma Corp in one report.

$295

Buy Report View Sample

Save hours of research time and resources with
our up-to-date GC Biopharma Corp Strategy Report
Understand GC Biopharma Corp position in the market,
performance and strategic initiatives.
Gain competitive edge and increase your
chances of success

GC Biopharma Corp: Patents

View up-to-date information on GC Biopharma Corp patents, including inventor and filing insights.

Publication Identifier	Document Type	Title	Classification-CPC	Publication Date
WO2022177230A1	Application	A COMPOSITION FOR TREATMENT OF HEPATITIS B COMPRISING HBV SPECIFIC ANTIBODY FOR COMBINATION WITH VACCINE COMPOSITION		August 25, 2022
EP4041733A1	Application	NEUARTIGE DERIVATE MIT 2,3-DIHYDRO-1H-INDEN- ODER 2,3-DIHYDROBENZOFURANTEIL ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON UND DIESE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN	A61K31/439; A61P25/16; A61P43/00; C07D453/02; C07D471/08	August 17, 2022
EP4041734A1	Application	NEUARTIGE DERIVATE MIT 1,2,3,4-TETRAHYDRONAPHTHALENEINHEIT ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON UND DIESE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN	A61K31/439; A61P25/16; A61P43/00; C07D453/02; C07D471/08	August 17, 2022
US20220251176A1	Application	FUSION PROTEIN COMPRISING ANTI-MESOTHELIN ANTIBODY, ANTI-CD3 ANTIBODY OR ANTI-EGFR ANTIBODY, BISPECIFIC OR TRISPECIFIC ANTIBODY COMPRISING SAME, AND USES THEREOF	A61K2039/505; A61P35/00; C07K16/18; C07K16/2809; C07K16/2863; C07K2319/30	August 11, 2022
US11401343B2	Grant	Anti-MSLN antibody and pharmaceutical composition for cancer treatment comprising same	A61K38/00; C07K16/3076; C07K2317/24; C07K2317/56; C12N15/85	August 02, 2022

Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Find out more

Name	Count

Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Find out more

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer